5 completed, 2 terminated, 1 withdrawn. 3 Not applicable, 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 3 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Diabetes, Type 1: new trials by email Literature Review of Diabetes, Type 1 trials Research Report on Diabetes, Type 1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hybrid Closed-Loop Insulin Delivery System in Type 1 Diabetes Candidates for a Living Donor Kidney Transplant Observation - Diabetes, Type 1 | Withdrawn | Yale University | 2018-08-31 | 2021-03-09 | ||
| Study of Insulin Pump in Prevention of Low Glucose Events in Adults With Type 1 Diabetes at Risk of Severe Hypoglycemia Minimed 640G with smartguard activated, Minimed 640G with smartguard off - Diabetes, Type 1 | Not applicable | Completed | University Hospital, Grenoble | 20 | 2016-02-01 | 2017-10-18 |
| Reimbursement Study of Continuous Glucose Monitoring in Belgium Diabetes, Type 1 | Completed | KU Leuven | 589 | 2014-09-01 | 2020-06-22 | |
| Edmonton Automated Sugar Intelligence - Intelligent Diabetes Management, EASI-IDM, App Program to Assist Diabetes Care EASI-IDM use - Diabetes, Type 1 | Not applicable | Completed | University of Alberta | 31 | 2014-08-01 | 2023-02-14 |
| Breakfast Nutrition and Inpatient Glycemia Modified Carbohydrate Breakfast, Control Breakfast - Diabetes, Type 1, Diabetes, Type 2 | Not applicable | Completed | Duke University | 237 | 2012-09-01 | 2015-10-14 |
| The Relationship of Hemoglobin A1c and Diabetic Wound Healing Bacitracin, AmeriGel®, Vitamin C - Diabetes, Type 1, Diabetes, Type 2 | Phase 4 | Terminated | Susan Hassenbein | 2 | 2012-02-01 | 2017-12-12 |
| Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks Technosphere Insulin, Insulin glargine, Insulin lispro - Diabetes, Type 1 | Phase 3 | Terminated | Mannkind Corporation | 130 | 2008-05-01 | 2014-10-16 |
| Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes Technosphere® Insulin Inhalation Powder, Usual Care - Diabetes, Type 1, Diabetes, Type 2 | Phase 3 | Completed | Mannkind Corporation | 2053 | 2005-06-01 | 2014-10-16 |
Diabetes Mellitus, Type 1 (8) · Diabetes Mellitus, Type 2 (3) · Cardiovascular Diseases (1) · Diabetic Foot (1) · Hyperglycemia (1) · Hypoglycemia (1)
Autoimmune Diseases (8) · Diabetes Mellitus (8) · Endocrine System Diseases (8) · Glucose Metabolism Disorders (8) · Immune System Diseases (8) · Metabolic Diseases (8) · Nutritional and Metabolic Diseases (8) · Cardiovascular Diseases (1) · Diabetes Complications (1) · Diabetic Angiopathies (1) · Diabetic Neuropathies (1) · Foot Ulcer (1) · Leg Ulcer (1) · Skin Diseases (1) · Skin Ulcer (1)
Ascorbic Acid (1) · Bacitracin (1) · Breakfast (1) · Carbohydrates (1) · Insulin Glargine (1) · Insulin Lispro (1) · Observation (1) · oak bark extract (1)
Mannkind Corporation (2) · Duke University (1) · KU Leuven (1) · Susan Hassenbein (1) · University Hospital, Grenoble (1) · University of Alberta (1) · Yale University (1)
United States (5) · Canada (2) · Brazil (1) · Czechia (1) · France (1) · Poland (1) · Russia (1) · Spain (1) · Ukraine (1) · United Kingdom (1)
Edmond Ryan, MD (1) · Kathryn J Evans, NP (1) · Lillian F Lien, MD (1) · Mark N Feinglos, MD (1) · Nell V. Blake, DPM (1) · Renata Belfort De Aguiar, MD, PhD (1)
PMID 27570203, PMID 29342264, PMID 33067260, PMID 36275049, PMID 38787436, PMID 38924290